Medicamen Organics IPO Details: The Medicamen Organics IPO date is set. It will open on June 21 and close on June 25. This NSE SME IPO aims to raise ₹10.54 crores. The IPO price band is set at ₹32 to ₹34, with a market lot of 4000 shares.
About the Company
Medicamen Organics Limited is involved in the development, manufacturing, and distribution of a wide range of pharmaceutical dosages, including tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. They serve both government (state and central) and private institutions as a contract/third-party manufacturer. Their products are marketed to private pharmaceutical companies domestically and internationally through third-party distributors or on a loan license basis.
The company is also focusing on establishing a direct presence in international markets, having directly exported to Burundi in fiscal 2023. They have a strong track record in the B2B sector, particularly in contract manufacturing. Medicamen Organics markets its products across India and internationally in regions such as Africa, CIS, and Southeast Asia, including countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, the Philippines, Myanmar, Mozambique, Burundi, Kyrgyzstan, and Kenya, through third-party distributors.
Company Overview
They have two WHO GMP-approved manufacturing facilities located at 60 and 61, Sector 6A, I.I.E. SIDCUL, Ranipur, Haridwar 249403, Uttarakhand, covering 21,536 sq. ft. These facilities are equipped to produce pharmaceutical formulations and products, supported by a fully equipped quality control department with experienced and qualified staff to ensure smooth manufacturing. They have an in-house testing laboratory and the necessary infrastructure to test raw materials and finished products to meet quality standards. The company is ISO 9001:2015 certified, with a core strength in product development and documentation, regularly engaging in research and development to launch new products. This approach ensures an ever-evolving product list and competitive market pricing.
Their product portfolio includes 84 products, covering a wide range of drugs such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, proton pump inhibitors, anti-histamines, anti-hypertensive drugs, anti-lipidemic drugs, anti-parasitic, multivitamins, multiminerals, and non-steroidal anti-inflammatory drugs (NSAIDs).
Medicamen Organics is consistent in supplying quality products year-round, complying with requisite safety standards. As a quality-conscious company, they continually strive to expand their product line, always seeking complementary products to enhance their range.
Objects of the Issue:
Funding expenses for product registration in international markets
Upgrading the plant and increasing production capacity
Funding working capital requirements
General corporate purposes
Medicamen Organics IPO Review
To be updated soon
Medicamen Organics IPO Date & Price Details
| IPO Open: | June 21, 2024 |
| IPO Close: | June 25, 2024 |
| IPO Size: | Approx ₹10.54 Crores, 3,100,000 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹32 to ₹34 Per Equity Share |
| IPO Listing on: | NSE SME |
| Retail Quota: | 35% of the net offer |
| QIB Quota: | 50% of the net offer |
| NII Quota: | 15% of the net offer |
Medicamen Organics IPO Market Lot
The minimum market lot for the Medicamen Organics IPO is 4000 shares, with an application amount of ₹136,000.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 4000 | ₹ 1,36,000 |
| Retail Maximum | 1 | 4000 | ₹ 1,36,000 |
| S-HNI Minimum | 2 | 8000 | ₹ 2,72,000 |
Medicamen Organics IPO Dates
The Medicamen Organics IPO will open on June 21 and close on June 25. The allotment date is June 26, and the IPO is expected to list on June 28.
| IPO Open Date: | June 21, 2024 |
| IPO Close Date: | June 25, 2024 |
| Basis of Allotment: | June 26, 2024 |
| Refunds: | June 27, 2024 |
| Credit to Demat Account: | June 27, 2024 |
| IPO Listing Date: | June 28, 2024 |
Peer Group
- Brooks Laboratories Ltd
- Cian Healthcare Ltd
- Zenotech Laboratories Ltd
Company Promoters
Mr. Bal Kishan Gupta
Medicamen Organics IPO Registrar
- Kfin Technologies Limited
- Phone: 04067162222, 04079611000
- Email: medicamen.ipo@kfintech.com
- Website: Kfintech IPO Status
Medicamen Organics IPO Allotment Status
Check the allotment status on the Kfintech website.
Medicamen Organics IPO Lead Managers (Merchant Bankers)
GYR Capital Advisors Private Limited
Company Address
- Medicamen Organics Limited
- 10 Community Centre,
- No 2 Ashok Vihar Phase II,
- New Delhi, Delhi, 110052
- Phone: +91-9818222845
- Email: cs@mediorganics.in
- Website: www.medicamenorganics.com
Medicamen Organics IPO FAQs
What is Medicamen Organics IPO?
Medicamen Organics IPO is an NSE SME IPO aiming to raise ₹10.54 crores, with an issue price of ₹32 to ₹34 per equity share. It will be listed on the NSE.
When will Medicamen Organics IPO open?
The IPO will open on June 21, 2024, for QIB, NII, and Retail Investors.
What is the investors’ portion for Medicamen Organics IPO?
The investors’ portion is 50% for QIB, 15% for NII, and 35% for Retail.
How to apply for the Medicamen Organics IPO?
You can apply via ASBA online through your bank account or via UPI through your stock brokers. You can also apply offline through your stock brokers.
How to apply for the Medicamen Organics IPO through Zerodha?
Log in to Console on the Zerodha website or app. Go to Portfolio, click on IPO, select “Medicamen Organics,” enter your UPI ID, quantity, and price, and submit the form. Approve the mandate on your UPI app.
How to apply for the Medicamen Organics IPO through Upstox?
Log in to the Upstox app, select the IPO, choose “Medicamen Organics,” click on the bid button, confirm your application, and approve the mandate on your UPI app.
How to apply for the Medicamen Organics IPO through Paytm Money?
Log in to the Paytm Money app, select the IPO, choose “Medicamen Organics,” click on the bid button, confirm your application, and approve the mandate on your UPI app.
What is the size of the Medicamen Organics IPO?
The size of the Medicamen Organics IPO is ₹10.54 crores